Primary Record
cefuroxime
- In stock
- 9,586 g
- Purity
- 98.1 %
- CAS
- 97232-97-8
Compound Identifiers & Properties
- CAS
- 97232-97-8
- PubChem CID
- 5361202
- SMILES
- CO/N=C(\C1=CC=CO1)/C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)O
- Canonical SMILES
- CO/N=C(/C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1
Names & Synonyms
- cefuroxime
- Cefuroxim
- Cephuroxime
- Cefuroxime Acid
- trans-Cefuroxime
- Biofuroksym
- Cefuril
- Kefurox
- Zinacef
- Ceftin
- Sharox
- Cefuroximo
- Cefuroximum
- Anaptivan
- Cepazine
- Maxipime
- Rocephin
- Cefizox
- Cefobid
- Cefotan
- Cefumax
- Cefurax
- Cefurex
- Duricef
- Elobact
- Kerurox
- Medoxim
- Mefoxin
- Monocid
- Velosef
- Cefzil
- Kefzol
- Kesint
- Mandol
- Oraxim
- Zinnat
- Ancef
- Cedax
- Zinat
- Zinacef Danmark
- Cefuroxime Free Acid
- Cefuroxime, trans-
- Z5PTJ86MTY
- Cefuroximum [INN-Latin]
- Cefuroximo [INN-Spanish]
- AC1NSF2E
- Desacetyloxyethyl (E)-Cefuroxime Axetil
- Prestwick2_000720
- RefChem:203329
- UNII-Z5PTJ86MTY
- Cefuroxime EP Impurity E
- 97232-97-8
- CHEMBL466
- UNII-O1R9FJ93ED
- Cefuroxime [USAN:BAN:INN]
- Cefuroxime sodium impurity E
- SCHEMBL40413
- C16H16N4O8S
- Cefuroxime Sodium EP Impurity E
- Cefuroxime [USAN:INN:BAN]
- 55268-75-2
- DTXCID302774
- Cefuroxime sodium impurity E [EP]
- DTXSID5022774
- CHEBI:94687
- JFPVXVDWJQMJEE-IZRZKJBUSA-N
- JFPVXVDWJQMJEE-SWWZKJRFSA-N
- DTXSID601369231
- STR09741
- ZINC3871978
- EINECS 259-560-1
- Tox21_111149
- Tox21_113378
- Tox21_200884
- BDBM50350472
- C16-H16-N4-O8-S
- MFCD23149061
- NCGC00091560-01
- AKOS037655932
- CID5361202
- CS-O-01078
- BRN 5783190
- Desethyl Acetate (E)-Cefuroxime Axetil
- NCGC00091560-02
- NCGC00091560-03
- NCGC00185751-01
- NCGC00258438-01
- CPD001496804
- SAM002589901
- CAS-55268-75-2
- NS00008662
- CEFUROXIME SODIUM IMPURITY E [EP IMPURITY]
- A900171
- CEFUROXIME SODIUM IMPURITY E (EP IMPURITY)
- (6R,7R)-3-(carbamoyloxymethyl)-7-[[(2E)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- BRD-K63641886-236-01-9
- Q63409033
- CEFUROXIME SODIUM EP IMPURITY E (REFERENCE GRADE)
- (6R,7R)-3-(((Aminocarbonyl)oxy)methyl)-7-(((2E)-2-(2-furanyl)-2-(methoxyimino)acetyl)amino)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
- 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-(((2E)-2-(2-furanyl)-2-(methoxyimino)acetyl)amino)-8-oxo-, (6R,7R)-
- (6R,7R)-3-(carbamoyloxymethyl)-7-[[(2E)-2-(2-furyl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 3-(((AMINOCARBONYL)OXY)METHYL)-7-((2-FURANYL(METHOXYIMINO)ACETYL)AMINO)-8-OXO-, (6R-(6.ALPHA.,7.BETA.(E)))-
- 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-((2-furanyl(methoxyimino)acetyl)amino)-8-oxo-, (6R-(6alpha,7beta(E)))-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,3-[[(aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-furanyl(methoxyimino)acetyl]amino]-8-oxo-, (6R,7R)-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,3-[[(aminocarbonyl)oxy]methyl]-7-[[2-furanyl(methoxyimino)acetyl]amino]-8-oxo-, [6R-[6a,7b(E)]]-
- (6R,7R)-3-((Carbamoyloxy)methyl)-7-((E)-2-(furan-2-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
- (6R,7R)-3-[(carbamoyloxy)methyl]-7-[(2E)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (6R,7R)-3-[(carbamoyloxy)methyl]-7-[[(E)-(furan-2-yl)(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (6R,7R)-3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (6R,7R)-3-{[(aminocarbonyl)oxy]methyl}-7-({(2E)-2-furan-2-yl-2-[(methyloxy)imino]acetyl}amino)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (6R,7R)-3-carbamoyloxymethyl-7-[(Z)-2-(fur-2-yl)-2-methoxyiminoacetamido]-ceph-3-em-4-carboxylic Acid
- (6r,7r)-3-carbamoyloxymethyl-7-[(z)-2-(fur-2-yl)-2-methoxyiminoacetamido]ceph-3-em-4-carboxylic acid
- (6R,7R)-3-Carbamoyloxymethyl-7-[Z-2-(fur-2-yl)-2-methoxyiminoacetamido]ceph-3-em-4-carboxylic acid
- (6R,7R)-7-(2-(2-Furyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid 7(sup 2)-(Z)-(O-methyloxime) carbamate (ester)
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl] -7-[[(2Z)-2-furanyl(methoxyimino)acetyl]amino ]-8-oxo-, (6R,7R)-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-[[(2E)-2-(2-furanyl)-2-(methoxyimino)-1-oxoethyl]amino]-8-oxo-, monosodium salt, (6R,7R)-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-[[(2E)-2-(2-furanyl)-2-(methoxyimino)acetyl]amino]-8-oxo-, (6R,7R)-; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-[[2-furanyl(methoxyimino)acetyl]amino]-8-oxo-, [6R-[6a,7ss(E)]]- (9CI); (6R,7R)-3-[[(Aminocarbonyl)oxy]methyl]-7-[[(2E)-2-(2-furanyl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cefuroxime Imp. E (EP); trans-Cefuroxime; (E)-Cefuroxime; Desacetyloxyethyl (E)-Cefuroxime axetil; (6R,7R)-3-[(Carbamoyloxy)methyl]-7-[[(E)-(furan-2-yl)(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-(2-furanyl)-2-(methoxyimino)acetyl]amino]-8-oxo-, (6R,7R)-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-furanyl(methoxyimino)acetyl]amino]-8-oxo-, (6R,7R)-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-[[2-furanyl(methoxyimino)acetyl]amino]-8-oxo-, [6R-[6.alpha.,7.beta.(Z)]]-